Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04983121 | Efficacy and Safety of Pyrotinib Maleate Combined With ARX788 Neoadjuvant Treatment in Breast Cancer Patients | recruiting | Phase 2 | 30 | Shengjing HospitalOTHER | 1 | Sep 13, 2022 | clinicaltrials |
| NCT05228951 | Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBC | recruiting | Phase 2 | 12 | Shengjing HospitalOTHER | 1 | Sep 13, 2022 | clinicaltrials |
| NCT05263570 |
| The Efficiency for Stage II-III HR+/HER2+ Early Breast Cancer Patient With Standard Neoadjuvant Therapy in Real World. |
| recruiting |
| — |
| 200 |
| Shengjing HospitalOTHER |
| 1 |
| Sep 13, 2022 |
| clinicaltrials |
| NCT04486495 | Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer(MINIMAX) | recruiting | — | 549 | Maastricht University Medical CenterOTHER | 1 | Aug 24, 2022 | clinicaltrials |
| NCT04698252 | Local Therapy for ER/PR-positive Oligometastatic Breast Cancer(LARA) | recruiting | Phase 2 | 74 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Aug 8, 2022 | clinicaltrials |
| NCT05491395 | Hypofractionated Radiotherapy in Breast Cancer Patients With Prosthetic Reconstruction(PROMART) | recruiting | N/A | 120 | Barretos Cancer HospitalOTHER | 1 | Aug 8, 2022 | clinicaltrials |
| NCT04985032 | Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT) | recruiting | — | 200 | RPCR, Inc.OTHER | 1 | Aug 5, 2022 | clinicaltrials |
| NCT05305092 | Assessment of Brain Cognitive Impairment in Breast Cancer | recruiting | — | 90 | Tang-Du HospitalOTHER | 1 | Jul 13, 2022 | clinicaltrials |
| NCT05420454 | A Study for the Neoadjuvant Treatment of Breast Cancer | recruiting | Phase 4 | 1,576 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jul 1, 2022 | clinicaltrials |
| NCT05420467 | A Study for the Adjuvant Treatment of Breast Cancer | recruiting | Phase 4 | 2,413 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jul 1, 2022 | clinicaltrials |
| NCT05427071 | Magnetic Marker Localization for Occult Breast Cancer and Target Axillary Dissection in Node-positive Breast Cancer Post-neoadjuvant Chemotherapy(MaCTAD) | recruiting | N/A | 30 | The University of Hong KongOTHER | 1 | Jun 22, 2022 | clinicaltrials |
| NCT05341141 | Effectiveness of Cryotherapy Combined With Compression Therapy for Preventing Chemotherapy-induced Peripheral Neuropathy | recruiting | N/A | 102 | Peking UniversityOTHER | 1 | Jun 13, 2022 | clinicaltrials |
| NCT03829553 | Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard Treatment(HARVEST) | recruiting | Phase 3 | 801 | Ruijin HospitalOTHER | 1 | Jun 2, 2022 | clinicaltrials |
| NCT04079049 | BreCLIM-2 - A RCT Investigating Local Treatment for Breast Cancer Liver Metastases(BreCLIM-2) | recruiting | Phase 3 | 200 | Umeå UniversityOTHER | 1 | May 25, 2022 | clinicaltrials |
| NCT04065321 | Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer | recruiting | — | 500 | Shengjing HospitalOTHER | 1 | May 5, 2022 | clinicaltrials |
| NCT05037825 | The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors(PARADIGM) | recruiting | — | 800 | VastBiomeINDUSTRY | 1 | Apr 27, 2022 | clinicaltrials |
| NCT05334459 | Preoperative Radiotherapy and Systemic Therapy Following Surgery in 'de Novo' Metastatic Breast Cancer | recruiting | — | 40 | Ankara Oncology Research and Training HospitalNETWORK | 1 | Apr 26, 2022 | clinicaltrials |
| NCT05345860 | Adopting the MRD Strategy to Optimize Post-operation Adjuvant Therapies for Early Stage Breast Cancer(AMENDER) | recruiting | N/A | 300 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Apr 26, 2022 | clinicaltrials |
| NCT04666961 | Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ(HORNEO01) | recruiting | Phase 2 | 262 | Institut Cancerologie de l'OuestOTHER | 1 | Apr 22, 2022 | clinicaltrials |
| NCT05326295 | Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients | recruiting | — | 1,000 | Hunan Cancer HospitalOTHER | 1 | Apr 13, 2022 | clinicaltrials |
| NCT04478851 | EXCEL: Exercise for Cancer to Enhance Living Well(EXCEL) | recruiting | N/A | 1,500 | University of CalgaryOTHER | 1 | Mar 31, 2022 | clinicaltrials |
| NCT05292742 | Compare Continuation of Original Targeted Therapy With Trastuzumab Combined With Pyrotinib and Capecitabine as Postoperative Adjuvant Therapy in Non-pCR Patients With HER2 Positive Early Breast Cancer | recruiting | Phase 2 | 206 | Fujian Medical University Union HospitalOTHER | 1 | Mar 23, 2022 | clinicaltrials |
| NCT04159818 | Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Patients(TONIC-2) | recruiting | Phase 2 | 52 | The Netherlands Cancer InstituteOTHER | 1 | Mar 22, 2022 | clinicaltrials |
| NCT05241119 | Axillary Lymph Node Treatment Guided by Naocarbon Tracing After Neoadjuvant Chemotherapy | recruiting | N/A | 100 | Shengjing HospitalOTHER | 1 | Feb 15, 2022 | clinicaltrials |
| NCT02535221 | Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer | recruiting | Phase 3 | 234 | Peking UniversityOTHER | 1 | Nov 29, 2021 | clinicaltrials |
| NCT05059379 | Medial vs. Entire Supraclavicular Lymph Node Radiation Therapy for Patients With Invasive Breast Cancer(SUCLANODE) | recruiting | Phase 3 | 1,650 | Fudan UniversityOTHER | 1 | Oct 25, 2021 | clinicaltrials |
| NCT05057598 | DianaWeb: Before and After Study Online Based Participatory Research on Breast Cancer Women(DianaWeb) | recruiting | N/A | 50,000 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Sep 27, 2021 | clinicaltrials |
| NCT05032768 | The Association Between Radiation Dermatitis and Skin Microbiome in Breast Cancer Patients | recruiting | — | 100 | Fudan UniversityOTHER | 1 | Sep 2, 2021 | clinicaltrials |
| NCT05010356 | Insulin Sensitivity After Breast Cancer | recruiting | N/A | 24 | University of CopenhagenOTHER | 1 | Aug 18, 2021 | clinicaltrials |
| NCT04993014 | Circulating Tumor Cells and Treatment De-escalation After Neoadjuvant Therapy for HER2 Positive Breast Cancer(HER2Cell) | recruiting | Phase 2 | 80 | AC Camargo Cancer CenterOTHER | 1 | Aug 6, 2021 | clinicaltrials |
| NCT04261829 | AFT: Introduction of a Full Breast Reconstructive Method(BREAST-II) | recruiting | — | 350 | Maastricht University Medical CenterOTHER | 1 | Jul 29, 2021 | clinicaltrials |
| NCT04136782 | Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer | recruiting | Phase 4 | 110 | Shengjing HospitalOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT04137653 | Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT | recruiting | Phase 3 | 1,498 | Shengjing HospitalOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT04476485 | Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy | recruiting | — | 1,000 | Shengjing HospitalOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT03787056 | Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients(ONCOPRO) | recruiting | N/A | 410 | Hospices Civils de LyonOTHER | 1 | Jul 16, 2021 | clinicaltrials |
| NCT04960839 | Prophylactic Irradiation to the Contralateral Breast for BCAs Patients(PICB) | recruiting | N/A | 323 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 2 | Jul 14, 2021 | clinicaltrials |
| NCT04947280 | Single Arm Phase II Study of Fractionated Stereotatic Radiation Therapy (FSRT) for Bone Metastases in Breast Cancer | recruiting | Phase 1 / Phase 2 | 120 | Fudan UniversityOTHER | 1 | Jul 1, 2021 | clinicaltrials |
| NCT04878666 | Prospective Assessment of Quality of Life in Patients With Locally Recurrent Breast Cancer and Hyperthermic Radiotherapy(UKT HT03_1) | recruiting | — | 20 | University Hospital TuebingenOTHER | 1 | May 7, 2021 | clinicaltrials |
| NCT04019678 | Breast Cancer: Axillary Conservation After Neoadjuvant Chemotherapy in Micro Metastatic Sentinel Lymph Nodes.(NEONOD2) | recruiting | N/A | 850 | Istituto Clinico HumanitasOTHER | 1 | Apr 19, 2021 | clinicaltrials |
| NCT04669873 | Accelerated Partial Breast Irradiation Versus Standard or Hypofractionated Whole-Breast Irradiation, in Early Breast Cancer, After Breast-conserving Surgery(LAPIDARY) | recruiting | N/A | 36 | Instituto Brasileiro de Controle do CancerOTHER | 1 | Mar 8, 2021 | clinicaltrials |
| NCT04665882 | Nomogram to Predict Breast Cancer Related Lymphedema | recruiting | N/A | 600 | Wuhan UniversityOTHER | 1 | Dec 16, 2020 | clinicaltrials |
| NCT04646759 | Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast Cancer | recruiting | Phase 3 | 516 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Nov 30, 2020 | clinicaltrials |
| NCT03591276 | Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast Cancer(KEYDOX) | recruiting | Phase 1 / Phase 2 | 15 | Shaare Zedek Medical CenterOTHER | 1 | Oct 23, 2020 | clinicaltrials |
| NCT04291378 | The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast Cancer | recruiting | N/A | 1,502 | Danish Breast Cancer Cooperative GroupOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT04481763 | A Study of the Efficacy and Safety of Camrelizumab Plus Radiotherapy for Patients With Early Triple-Negative Breast | recruiting | Phase 1 / Phase 2 | 20 | Jiangxi Provincial Cancer HospitalOTHER | 1 | Jul 22, 2020 | clinicaltrials |
| NCT04481932 | Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer | recruiting | Phase 2 | 104 | Peking UniversityOTHER | 1 | Jul 22, 2020 | clinicaltrials |
| NCT04072653 | Sentinel Node Biopsy Vs Observation After Axillary PET(SOAPET) | recruiting | N/A | 1,528 | Fudan UniversityOTHER | 1 | Jul 13, 2020 | clinicaltrials |
| NCT03667417 | Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation(GENEPSO) | recruiting | — | 5,000 | Institut Paoli-CalmettesOTHER | 1 | Jul 1, 2020 | clinicaltrials |
| NCT04437160 | Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy | recruiting | Phase 2 | 286 | Chinese Academy of Medical SciencesOTHER | 1 | Jun 18, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Sep 13, 2022source: clinicaltrials